Skip to main content

All Miami Cancer Institute

Submissions from 2020 2020

NRG/RTOG 1122: A phase 2, double-blinded, placebo-controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma, Minesh Mehta

Association of Programmed Death 1 Protein Ligand (PD-L1) Expression With Prognosis in Merkel Cell Carcinoma, Guilherme Rabinowits

Psychosocial Support for Pediatric Patients at Proton Therapy Institutions, Nicole Boik and Matthew Hall

Abstract B054: Analysis of a cancer gene expression and next-generation sequencing dataset representing hispanic predominant South Florida population, Zuanel Diaz, Arpit Mehta, Zasha Pou, Muni Rubens, Don Parris, and Miguel Villalona Calero

Beyond an Updated Graded Prognostic Assessment (Breast GPA): A Prognostic Index and Trends in Treatment and Survival in Breast Cancer Brain Metastases From 1985 to Today, John Bryant, Michael Chuong, and Minesh Mehta

Overactive bladder and urgency urinary incontinence in men undergoing artificial urinary sphincter placement, Christopher Gomez

Pediatric bithalamic gliomas have a distinct epigenetic signature and frequent EGFR exon 20 insertions resulting in potential sensitivity to targeted kinase inhibition, Matthew Hall and Minesh Mehta

Safety of bloodless autologous stem cell transplantation in Jehovah's Witness patients, Muni Rubens

SAGES and EAES recommendations for minimally invasive surgery during COVID-19 pandemic, Horacio Asbun

Standardized Risk Assessment and Risk-Stratified Venous Thromboembolism Prophylaxis for Patients Undergoing Breast Operation, Jane Mendez

Endovascular Treatment of Giant Intracranial Aneurysms, Italo Linfante, FIU Herbert Wertheim College of Medicine Affiliates, Amy Starosciak, and Guilherme Dabus

Phase I study of 9-ing-41, a small molecule selective glycogen synthase kinase-3 beta (GSK-3β) inhibitor, as a single agent and combined with chemotherapy, in patients with refractory tumors, Bruno Bastos

Single-agent ONC201 in recurrent H3 K27M-mutant diffuse midline glioma, Yazmin Odia and Minesh Mehta

Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients, Minesh Mehta

Extreme Intracranial Hypotension With Brain Herniation Treated With Repeat Bolus Intrathecal Infusions, Kevin Abrams and Vitaly Siomin

Abstract 256: Length of Stay, Type of Stroke and NIHSS Score in Persons With Self-reported Diabetes, Amy Starosciak and Felipe De los Rios La Rosa

Analyzing the role of adjuvant or salvage radiotherapy for spinal myxopapillary ependymomas, Rupesh Kotecha

Calcitonin prescribing criteria for the management of hypercalcemia in a community hospital, Jessica Hernandez, Radhan Gopalani, Heidi Clarke, Joyce Lee, and Alyssa Donadio

Current approaches to the management of brain metastases, Rupesh Kotecha

Definitive maxillary obturator prosthesis: Timelines for fabrication and follow-up, Evan Rosen

Evaluation of clinical outcomes of 4-factor prothrombin complex concentrate versus andexanet alfa in the treatment of intracerebral hemorrhage, Eduardo Guizan Corrales, Radhan Gopalani, Heidi Clarke, Jonatha Kline, Felipe De Los Rios La Rosa, and Thomas Wolfel

Melflufen plus dexamethasone in relapsed and refractory multiple myeloma (O-12-M1): a multicentre, international, open-label, phase 1-2 study, Claudia Paba Prada

Recent Health Care Expenditure Trends Among Adult Cancer Survivors in United States, 2009-2016, Muni Rubens, Anshul Saxena, Sankalp Das, Chintan Bhatt, Emir Veledar, Peter McGranaghan, Ana Viamonte Ros, Yuliya Linhares, Yazmin Odia, Michael Chuong, Rupesh Kotecha, and Minesh Mehta

Review of adjunctive midodrine to facilitate weaning intravenous vasopressors in critically ill patients, Claudia Martin Diaz, Heidi Clarke, Payal Patel, Radhan Gopalani, and Stephanie Palma

Safe implementation of minimally invasive pancreas resection: a systematic review, Horacio Asbun